Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ibuprofen Formulations in Healthy Subjects
NCT02256423Phase 1Completed
- Sponsor
- Simbec-Orion
- Start
- Jul 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain, fever and inflammation (3 arms), sponsored by Simbec-Orion. Primary endpoint: Pharmacokinetics at 12 hours. Started Jul 2014; status: completed.
02
Drugs
ibuprofen
03
Conditions
painfeverinflammation
Beyond the preview
Go deeper on NCT02256423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256423.